Health Condition 1: O135- Gestational [pregnancy-induced] hypertension without significant proteinuria, complicating the puerperium
Conditions
Interventions
Intervention1: Group B-Postpartum women receiving oral Nifedipine: Nifedipine will be started at 10 mg BD initially, and then the dose will be increased not more than 60 mg/day till 6 weeks
Control I
Sponsors
Department of Obstetrics and Gynaecology
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women having persistent postpartum hypertension with BP more than 150 by 100 mmHg up to 160 by 110 mmHg. 2. Women delivered at the gestational age of more than 24 weeks. 3. Women willing to follow up for up to 6 weeks. 4. Women willing to participate in the study. 5. Postpartum women having gestational hypertension, pre-eclampsia, chronic hypertension, and de novo postpartum hypertension.
Exclusion criteria
Exclusion criteria: 1. Women allergic to nifedipine or labetalol. 2. Women with a heart rate less than 60 beats per minute or more than 110 beats per minute. 3. Women having cardiac disease. 4. Women having renal disease with serum creatinine level more than 1 mg per dl. 5. Women having uncontrolled diabetes mellitus, bronchial asthma, and eclampsia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure measurementTimepoint: Serial blood pressure measurements will be done hourly for the first 6 hours, and then 4 hourly for the next 24 hours, and then follow-up will be taken after 2 weeks, and then after 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| NoneTimepoint: None | — |
Countries
India
Contacts
Public ContactDr Kanchan Dwidmuthe
NKP Salve Institute of Medical Sciences and Research Center and Lata Mangeshkar Hospital , Nagpur
Outcome results
None listed